WithdrawnPhase 2NCT01280669

Intravitreal Sirolimus as Therapeutic Approach to Uveitis

Studying Infectious panuveitis

Last synced from ClinicalTrials.gov April 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Stanford University
Principal Investigator: Quan D Nguyen, MD, MSc
Stanford University Byers Eye Institute
Intervention: Intravitreal injection 440mcg(drug)
Eligibility: 18 years · All sexes
Timeline: 2022 – 2024

Study locations (1)

Stanford University, Palo Alto, California, United States

Collaborators

Santen Inc.

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01280669 on ClinicalTrials.gov

← Back to all trials